Institute of Progressive Medicine Facilitates IMULUX Herpes Challenge

Share Article

Institute of Progressive Medicine will facilitate the IMULUX million dollar herpes challenge.

This may be a tremendous opportunity to help educate the medical profession and patients experiencing recurrent herpes virus outbreaks about an auxiliary defense mechanism mediated through an alternative cellular energy (ACE) pathway.

Imulux Ltd has recently challenged the scientific community to disprove its findings of the complete healing of genital and oral herpes virus infections using a patented energy medicine treatment protocol.

Dr. Stoneburner, the owner of Imulux Ltd, is so convinced of this method from the outstanding success of many clinical trials, that he has offered a $1,000,000.00 reward to anyone who can prove him wrong. The Center For Complex Infectious Diseases with the support of The Institute of Progressive Medicine has agreed to assist those willing to accept Dr. Stoneburner’s challenge by providing details of his method and of the presumed mode of action.

The Institute is currently pursuing its own studies on this procedure under an FDA approved clinical study protocol. Dr. W. John Martin, M.D., Ph.D., from the Institute of Progressive Medicine recently informed his colleagues: “This may be a tremendous opportunity to help educate the medical profession and patients experiencing recurrent herpes virus outbreaks about an auxiliary defense mechanism mediated through an alternative cellular energy (ACE) pathway.” According to Dr. Martin, the ACE pathway plays an important role in suppressing infections caused by stealth adapted viruses that are not effectively recognized by the cellular immune system. The Imulux protocol is a perfect example of a time tested ACE pathway.

“The immune system is not always adequate to stop recurrent outbreaks of herpes simplex virus (HSV) infections,” explains Dr. Martin. “Typically, patients with oral or genital HSV lesions are prescribed antiviral drugs such as Acyclovir, or resort to slow- acting questionable procedures.” A far better approach, according to Dr. Martin, will be to stimulate the ACE pathway. “Moreover, we can learn from these studies how to apply this principle to other viral infections including HIV, human papillomavirus (HPV) and, of course, stealth-adapted viruses.”

Physicians and researchers interested in learning more about the ACE pathway and in responding to Dr. Stoneburner’s challenge http://www.imulux.com can contact the Institute of Progressive Medicine by phone to Dr. Martin at 626-616-2868.

The Institute of Progressive Medicine is a component of the Progressive University. The University intends to provide the general public with practical information concerning the prevention and therapy of common infectious, metabolic and degenerative diseases. An area of immediate concern is the detection and eradication of methicillin resistant Staphylococcus aureus (MRSA) infections. Again, anyone interested in participating in these training programs should contact the Institute.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

W. John Martin, M.D., Ph.D
Institute of Progressive Medicine
626-616-2868
Email >